Phosphonamidate and phosphothioate dipeptides as potential inhibitors of VanX. (Q31392938)

1 July 2017

title

Phosphonamidate and phosphothioate dipeptides as potential inhibitors of VanX. (English)

1 reference

1 July 2017

Yang KW

1

1 reference

1 July 2017

Brandt JJ

series ordinal

2

1 reference

1 July 2017

Chatwood LL

series ordinal

3

1 reference

1 July 2017

Crowder MW

series ordinal

4

1 reference

1 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Bioorganic & Medicinal Chemistry Letters

1 July 2017

published in

1 reference

1 July 2017

volume

10

1 reference

1 July 2017

issue

10

1 reference

1 July 2017

page(s)

1085-1087

1 reference

Overexpression, purification, and characterization of VanX, a D-, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147.

1 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Phosphinate analogs of D-, D-dipeptides: slow-binding inhibition and proteolysis protection of VanX, a D-, D-dipeptidase required for vancomycin resistance in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

The structure of VanX reveals a novel amino-dipeptidase involved in mediating transposon-based vancomycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Phosphonamidates as transition-state analogue inhibitors of thermolysin.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Synthesis and evaluation of inhibitors of bacterial D-alanine:D-alanine ligases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Continuous assay for VanX, the D-alanyl-D-alanine dipeptidase required for high-level vancomycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Enzyme and metabolic inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900186-4

7 January 2021

10.1016/S0960-894X(00)00186-4

Identifiers

DOI

1 reference

1 July 2017

1 reference